IL247346B
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
70 members in 42 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 201461953628 | United States of America | P | |
| 2015020343 | United States of America | W |
Members70
| Document | Office | Kind | |
|---|---|---|---|
| CA2942859A1 | Canada | A1 | |
| US2015258102A1 | United States of America | A1 | |
| WO2015138835A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201620505A | Taiwan Province of China | A | |
| AR099756A1 | Argentina | A1 | |
| AU2015229210A1 | Australia | A1 | |
| NI201600138A | Nicaragua | A | |
| SG11201607645TA | Singapore | A | |
| AP2016009494A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| KR20160126084A | Republic of Korea | A | |
| PH12016501794A1 | Philippines | A1 | |
| CN106163503A | China | A | |
| IL247346A0 | Israel | A0 | |
| IL247346D0 | Israel | D0 | |
| MX2016012009A | Mexico | A | |
| EP3116547A1 | European Patent Office (EPO) | A1 | |
| MA39734A | Morocco | A | |
| CU20160135A7 | Cuba | A7 | |
| CR20160477A | Costa Rica | A | |
| EA201691692A1 | Eurasian Patent Organization (EAPO) | A1 | |
| SV2016005277A | El Salvador | A | |
| JP2017508803A | Japan | A | |
| PE20170312A1 | Peru | A1 | |
| DOP2016000244A | Dominican Republic | A | |
| CL2016002308A1 | Chile | A1 | |
| BR112016021130A2 | Brazil | A2 | |
| SA516371814A | Saudi Arabia | A | |
| US9895378B2 | United States of America | B2 | |
| ZA201606646B | South Africa | B | |
| US2018125854A1 | United States of America | A1 | |
| JP6348616B2 | Japan | B2 | |
| US10071100B2 | United States of America | B2 | |
| TW201834658A | Taiwan Province of China | A | |
| TWI636798B | Taiwan Province of China | B | |
| JP2018154643A | Japan | A | |
| US2018344746A1 | United States of America | A1 | |
| ECSP16081557A | Ecuador | A | |
| EA032234B1 | Eurasian Patent Organization (EAPO) | B1 | |
| IL247346A | Israel | A | |
| IL247346BThis record | Israel | B | |
| EP3116547B1 | European Patent Office (EPO) | B1 | |
| AU2015229210B2 | Australia | B2 | |
| DK3116547T3 | Denmark | T3 | |
| EP3511019A1 | European Patent Office (EPO) | A1 | |
| LT3116547T | Lithuania | T | |
| PT3116547T | Portugal | T | |
| MA39734B1 | Morocco | B1 | |
| RS59035B1 | Serbia | B1 | |
| SI3116547T1 | Slovenia | T1 | |
| HUE043964T2 | Hungary | T2 | |
| SA516371814B1 | Saudi Arabia | B1 | |
| SA6656B1 | Saudi Arabia | B1 | |
| HRP20191187T1 | Croatia | T1 | |
| AU2019240695A1 | Australia | A1 | |
| PL3116547T3 | Poland | T3 | |
| RS59035B9 | Serbia | B9 | |
| ES2737692T3 | Spain | T3 | |
| ME03435B | Montenegro | B | |
| GEP20207083B | Georgia | B | |
| TWI693937B | Taiwan Province of China | B | |
| UA121967C2 | Ukraine | C2 | |
| MY178189A | Malaysia | A | |
| EP3511019B1 | European Patent Office (EPO) | B1 | |
| DK3511019T3 | Denmark | T3 | |
| CY1122078T1 | Cyprus | T1 | |
| CU24488B1 | Cuba | B1 | |
| CN106163503B | China | B | |
| US2021177857A1 | United States of America | A1 | |
| ES2834927T3 | Spain | T3 | |
| MX378984B | Mexico | B |
3 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF | |
| Patent renewedKB | KB |
Numbers
- Publication
- 247346
- Application
- 247346
Titles2
- English
- THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME
- Hebrew
- ננו–חלקיקים רפואיים המכילים חומר רפואי ושיטות להכנתם ושימוש בהם
Classification
- CPC, 18
- A61K31/5377
- A61K9/5146
- A61K47/12
- A61K9/5153
- A61K9/5123
- A61K9/107
- A61K9/51
- A61K9/1075
- A61K47/28
- A61K47/34
- A61P1/00
- A61P1/16
- A61P1/18
- A61P11/00
- A61P13/12
- A61P15/00
- A61P35/00
- A61P35/02
- IPC, 6
- A61K47 28
- A61K47 34
- A61K47 12
- A61K31 5377
- A61K9 107
- A61K9 51